STUDYING OF THE BENEFICIAL EFFECT OF INSULIN SENSITIZER ON THE CARBOHYDRATE AND LIPID METABOLISM IN PATIENTS WITH DIFFUSE TOXIC GOITRE AND INSULIN RESISTANCE
DOI:
https://doi.org/10.11603/1811-2471.2016.v0.i4.7077Keywords:
diffuse toxic goiter, insulin resistance, thyrozol, metformin, pioglitazone.Abstract
Recent studies have been focused on the decreased insulin sensitivity in patients with functional thyroid disorders in both hypo- and hyperthyroidism. The study has detected the positive influence of additionally prescribed insulin sensitizers to patients with diffuse toxic goitre and present insulin resistance to carbohydrate and lipid metabolism markers, as well as beneficial effect on thyroid function.
References
Borovykov V. STATISTICA: Yskusstvo analyza dannykh na kompʹyutere. Dlya professyonalov / V. Borovykov. – SPb: Pyter, 2001. –- 656 s.
Lishchuk O. Z. Analiz rezulʹtativ zastosuvannya PPAR-g ahonista piohlitazonu u khvorykh na dyfuznyy toksychnyy zob ta insulinorezystentnistʹ / O. Z. Lishchuk, O. P. Kikhtyak, KH. A. Moskva // East European Scientific Journal. – 2016. – Vol. 2, N 10. – P. 40–43.
Moskva KH. A. Vplyv insulinovykh sensytayzeriv na lipidnyy i vuhlevodnyy obmin u khvorykh z hipotyreozom ta insulinorezystentnistyu / KH. A. Moskva, L. YE. Lapovetsʹ, O. P. Kikhtyak // Acta Medica Leopoliensia. – 2013. – № 3. – S. 15–20.
Protokoly nadannya medychnoyi dopomohy khvorym iz patolohiyeyu endokrynnoyi systemy / Ukrayinsʹkyy naukovo-praktychnyy tsentr endokrynnoyi khirurhiyi, transplantatsiyi endokrynnykh orhaniv i tkanyn MOZ Ukrayiny. – K. : 2011. – 110 s.
Skybchyk V. A. Insulinorezystentnistʹ: klinichne znachennya, metody vyznachennya, pidkhody do likuvannya / V. A. Skybchyk // Ukr. med. chasopys. – 2006. – № 6 (56). – S. 61–67.
Tsentralʹni vazheli rozvytku peryferiynoyi insulinorezystentnosti /
O. P. Kikhtyak, YU. H. Orel, N. V. Skrypnyk, KH. A. Moskva // Klinichna endokrynolohiya ta endokrynna khirurhiya. – 2012. – № 2. – S. 16–18.
American Association of Clinical Endocrinologistsʺ comprehensive diabetes management algorithm consensus statement / A. J. Garber, M. J. Abrahamson, J. I. Barzilay [et al.] // Endocr. Pract. – 2013. – Vol. 19, No. 2. – P. 536–557.
Brenta G. Why can insulin resistance be a natural consequence of thyroid dysfunction ? / G. Brenta // J. Thyroid. Res. – 2011. – Vol. 3. – P. 129–138.
Crunkhorn S. Links between thyroid hormone action, oxidative metabolism, and diabetes risk ? / S. Crunkhorn, M. E. Patti // Thyroid. – 2008. – Vol. 18, No. 2. – P. 227–237.
Cytokines (interferon-g and tumor necrosis factor-a)-induced nuclear factor-kB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone / A. Antonelli, S. M. Ferrari, R. Fallahi [et al.] // Metabolism. – 2011. – Vol. 2. – P. 227–283.
Glycemic status in hyperthyroid subjects / D.T. Paul, F.H. Mollah, M.K Alam [et al.] // Mymensingh Med. J. – 2004. – Vol. 13 (1). – P. 71–75.
Jahagirdar V. Thyroid hormoneʺs role in regulating brain glucose metabolism and potentially modulating hippocampal cognitive processes / V. Jahagirdar, E. C. McNay // Metab. Brain. Dis. – 2012. – Vol. 27, No. 2. – P. 101–111.
Kalra S. Metformin: midlife maturity, maiden charm. / S. Kalra, P. Dhamija, A. K. Das // Indian. J. Endocrinol. Metab. – 2012. – Vol. 16, No. 6. – P. 1015–1018.
Monokine induced by interferon (IFN) (CXCL9) and IFN inducible T-Cell-Chemoattractant (CXCL11) involvement in Gravesʺ disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor – agonists / A. Antonelli, S. M. Ferrari, P. Fallahi [et al.] // Journal of Clinical Endocrinology and Metabolism. – 2009. – Vol. 94 (5). – P. 1803–1809.
Muniyappa R., Quon M. Insulin action and insulin resistance in vascular endothelium / R. Muniyappa, M. Quon // Curr. Opin. Clin. Nutr. Metab. Care. – 2007. – No. 32 (10). – P. 523–530.
Peroxisome proliferator-activated receptor-gamma-mediated positive energy balance in the rat is associated with reduced sympathetic drive to adipose tissues and thyroid status / W. T. Festuccia, S. Oztezcan, M. Laplante [et al.] // Endocrinology. – 2008. – Vol. 149, No. 5. – P. 2121 –2130.
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis / A. J. Sanyal, N. Chalasani, K. V. Kowdley [et al.] // N Engl J Med. – 2010. – Vol. 362. – P. 1675–1685.
Skeletal muscle insulin resistance in endocrine disease / M. Peppa, Ch. Koliaki, P. Nikolopoulos [et al.] // J. Biomed. Biotechnol. – 2010. – Vol. 1. – P. 200–213.
